Acute Hepatitis Attack After Exposure to Telithromycin

Clinical Therapeutics

Volumn 29, Issue 8, 2007, Pages 1725-1729

  Onur, Ozge ^a   Guneysel, Ozlem ^a   Denizbasi, Arzu ^a   Celikel, Cigdem ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

antibiotic; case report; hepatitis; hepatotoxicity; jaundice; telithromycin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; AMYLASE; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CERULOPLASMIN; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; IRON; MITOCHONDRION ANTIBODY; SMOOTH MUSCLE ANTIBODY; TELITHROMYCIN;

ACUTE HEPATITIS; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BODY HEIGHT; BODY WEIGHT; CASE REPORT; CERULOPLASMIN BLOOD LEVEL; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; ECHOGRAPHY; EMERGENCY WARD; FERRITIN BLOOD LEVEL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IRON BLOOD LEVEL; JAUNDICE; LIVER BIOPSY; MALAISE; MALE; MONONUCLEOSIS; NAUSEA; NAUSEA AND VOMITING; PRESCRIPTION; SEROLOGY; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

ACUTE DISEASE; ADULT; ANTI-BACTERIAL AGENTS; HEPATITIS, TOXIC; HUMANS; KETOLIDES; MALE; RESPIRATORY TRACT INFECTIONS;

EID: 34848866553     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2007.08.004     Document Type: Article

References (19)

1. Nicholson S., Douglas W., and Moellering R. Antimicrobial-associated acute hepatitis. Pharmacotherapy 22 (2002) 794-797
2. Thiim M., and Friedman L. Hepatotoxicity of antibiotics and antifungals. Clin Liver Dis 7 (2003) 381-399
3. Lee W. Drug-induced hepatotoxicity. N Engl J Med 349 (2003) 474-485
4. Ganey P., Luyendyk J., Maddox J., and Roth I. Adverse hepatic drug reactions: Inflammatory episodes as consequence and contributor. Chem Biol Interact 50 (2004) 35-51
5. Zimmerman H. Hepatotoxicity. Dis Mon 39 (1993) 675-787
6. Nguyen M., and Chung E. Telithromycin: The first ketolide antimicrobial. Clin Ther 27 (2005) 1144-1163
7. Ketek (telithromycin) tablets [package insert] (2004), Aventis Pharmaceuticals Inc, Kansas City, Mo
8. Edwards I., and Aronson J. Adverse drug reactions: Definitions, diagnosis, and management. Lancet 356 (2000) 1255-1259
9. Sacher I., McPherson I., and Campos J. Widmann's Clinical Interpretation of Laboratory Tests. 11th ed. (2000), FA Davis Co, Philadelphia, Pa
10. World Health Organization (WHO). Adverse drug reaction definition. Safety of Medicines: A guide to detecting and reporting adverse drug reactions [WHO Web site]. Available at:. http://whqlibdoc.who.int/hq/2002/WHO_EDM_QSM_2002.2.pdf Accessed February 2, 2007
11. Naranjo C., Busto U., Sellers E., et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30 (1981) 239-245
12. US Food and Drug Administration (FDA). FDA completes safety assessment of Ketek new safety information to be added to product labeling [FDA Web site]. Available at. http://www.fda.gov/bbs/topics/NEWS/2006/NEW01401.html Accessed February 2, 2007
13. Clay K., Hanson J., and Pope S. Brief communication: Severe hepatotoxicity oftelithromycin: Three case reports and literature review. Ann Intern Med 144 (2006) 415-420
14. Pompili M., Basso M., Grieco A., et al. Recurrent acute hepatitis associated with use of cetirizine. Ann Pharmacother 38 (2004) 1844-1847
15. Breuskin F., Horsmans Y., Rahier J., and Lambert M. Recurrent immunoallergic hepatitis related to amoxicillinclavulanic acid. Acta Clin Belg 56 (2001) 255-257
16. Koklu S., Yuksel O., Filik L., et al. Recurrent cholestasis due to ampicillin. Ann Pkarmacotker 37 (2003) 395-397
17. Navarro J., Gallego E., and Aviles J. Recurrent severe acute hepatitis and omeprazole. Ann Intern Med 127 (1997) 1135-1136
18. Wong D., Blumberg D., and Lowe L. Guidelines for the use of antibiotics in acute upper respiratory tract infections. Am Faro Physician 74 (2006) 956-966
19. File Jr. T., and Hadley J. Rational use of antibiotics to treat respiratory tract infections. Am J Manag Care 8 (2002) 713-727